NIH Registers PMCF Study for Tears Naturale Eye Drops
Summary
NIH has registered a post-market clinical follow-up (PMCF) study (NCT07540884) evaluating the effectiveness and safety of Tears Naturale Free and Tears Naturale II lubricant eye drops in subjects with dry eye disease. The study will assess both products as lubricating eye drop interventions. This is a clinical trial registration entry on ClinicalTrials.gov, providing public access to study details and recruitment information.
What changed
NIH registered a new post-market clinical follow-up study on ClinicalTrials.gov for Tears Naturale Free and Tears Naturale II lubricant eye drops. The study aims to describe the effectiveness and safety of these over-the-counter lubricating eye drops in subjects experiencing dry eye disease symptoms.
Affected parties include pharmaceutical manufacturers marketing lubricant eye drops, clinical investigators conducting ophthalmic research, and healthcare providers prescribing dry eye treatments. As a clinical trial registration record, this document does not impose compliance obligations but provides transparency into ongoing post-market safety surveillance for these products.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Evaluation of Tears Naturale® Free and Tears Naturale® II Lubricant Eye Drops
N/A NCT07540884 Kind: NA Apr 21, 2026
Abstract
The purpose of this post-market clinical follow-up (PMCF) study is to describe the effectiveness and safety of Tears Naturale® Free and Tears Naturale® II lubricant eye drops in subjects experiencing dry eye (DE) symptoms.
Conditions: Dry Eye Disease
Interventions: Tears Naturale Free lubricating eye drops, Tears Naturale II lubricating eye drops
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.